Buy (150 RUB)
|Generate QR code
Open Access
Subscription or Fee Access
Interpretation of electrocardiograms and results of daily ECG Holter monitoring in patients with an implanted cardiac contractility modulator
https://doi.org/10.33667/2078-5631-2024-6-21-26
Abstract
Cardiac contractility modulation (CCM) is a method of non-drug treatment of chronic heart failure (CHF) in patients with no indications for resynchronization therapy. Now, a detailed study of this method and its capabilities is ongoing, and the indications for its use are expanding. As with any other implantable device, it is important to be able to monitor the operation of the CCM, identify its dysfunction and promptly refer patients to specialized institutions. Assessment of the function of CCM- therapy can be carrying out by recording a standard 12‑channel electrocardiogram (ECG), as well as 24‑hour Holter ECG monitoring (HM-ECG). The mechanism of action of CCM-therapy is fundamentally different from that of other implantable devices. Knowledge of the features of the manifestation of CCM-therapy during instrumental studies is necessary for their correct interpretation.
About the Authors
V. A. Amanatova
Federal State Budget Organization National Medical Research Center of Cardiology named after academician E. I. Chazov, Ministry of Healthcare Russian Federation
Russian Federation
Russian Federation
Amanatova Valeria Alexandrovna
T. M. Uskach
Federal State Budget Organization National Medical Research Center of Cardiology named after academician E. I. Chazov, Ministry of Healthcare Russian Federation; Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Tatyana Markovna Uskach
A. K. Vashtanian
Federal State Budget Organization National Medical Research Center of Cardiology named after academician E. I. Chazov, Ministry of Healthcare Russian Federation
Russian Federation
Russian Federation
Vashtanian Albert Karapetovich
D. V. Drozdov
Federal State Budget Organization National Medical Research Center of Cardiology named after academician E. I. Chazov, Ministry of Healthcare Russian Federation
Russian Federation
Russian Federation
Drozdov Dmitrii Vladimirovich
References
1. Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.) doi:10.15829/1560-4071-2020-4083 https://russjcardiol.elpub.ru ISSN 1560-4071 (print) doi:10.15829/1560-4071-2020-4083 ISSN 2618-7620 (online).
2. Lund LH, Jurga J, Edner M, Benson L, Dahlström U, Linde C, Alehagen U. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. Eur Heart J. 2013 Feb;34(7):529-39. doi: 10.1093/eurheartj/ehs305. Epub 2012 Oct 4. PMID: 23041499.
3. Oyenuga O, Hara H, Tanaka H, Kim HN, Adelstein EC, Saba S, Gorcsan J 3rd. Usefulness of echocardiographic dyssynchrony in patients with borderline QRS duration to assist with selection for cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2010 Feb;3(2):132-40. doi: 10.1016/j.jcmg.2009.09.020. PMID: 20159638.
4. Zhu H, Zou T, Zhong Y, Yang C, Ren Y, Wang F. Prevention of non-response to cardiac resynchronization therapy: points to remember. Heart Fail Rev. 2020 Mar;25(2):269-275. doi: 10.1007/s10741-019-09834‑w. PMID: 31352624; PMCID: PMC7046599.
5. Thibault B, Harel F, Ducharme A, et al. Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation. 2013;127:873-81. doi: 10.1161/CIRCULATIONAHA.112.001239.
6. A Kuck KH, Bordachar P, Borggrefe M, et al. New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace. 2014;16:109-28. doi: 10.1093/europace/eut311.
7. Masarone D, Rao I, Pacileo G. HOPE for a better selection of patients for cardiac contractility modulation, Expert Review of Medical Devices, 2023. 20:7, 525-528, DOI: 10.1080/17434440.2023.2217329.
8. Kleemann T. Cardiac contractility modulation. A new form of therapy for patients with heart failure and narrow QRS complex? Herz. 2015 Nov;40(7):945-51. doi: 10.1007/s00059-015-4362-8.
9. Amanatova VA, Safiullina AA, Uskach TM, Grishin IR, Sapelnikov OV, Tereshchenko SN. Implantation of cardiac contractility modulation device. (Analysis of complications in a 24‑month follow-up). Russian Cardiology Bulletin. 2023;18(1):65-72. (In Russ.) https://doi.org/10.17116/Cardiobulletin20231801165.
10. Uskach T. M., Sapelnikov O. V., Safiullina A. A., Grishin I. R., Amanatova V. A., Akchurin R. S., Tereshchenko S. N. Implantation of a cardiac contractility modulator in chronic heart failure and atrial fibrillation: results of a 6‑month follow-up of one hundred patients. Russian Journal of Transplantology and Artificial Organs. 2021;23(1):30-37. https://doi.org/10.15825/1995-1191-2021-1-30-37.
11. Safiullina AA, Uskach TM, Obraztsov IV, Akchurin RS, Saidova MA, Sapelnikov OV, Grishin IR, Cherkashin DI, Amanatova VA, Tereshchenko SN. Life expectancy in patients with chronic heart failure, atrial fibrillation and implantable cardiac contractility modulation devices. Russian Cardiology Bulletin. 2023;18(1):38-48. (In Russ.) https://doi.org/10.17116/Cardiobulletin20231801138.
12. Safiullina AA, Uskach TM, Sapelnikov OV, Grishin IR, Cherkashin DI, Amanatova VA, Akchurin RS, Tereshchenko SN. The effectiveness of cardiac contractility modulation in patients with chronic heart failure and atrial fibrillation: results of the 12‑month follow-up. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(9):1078-1084. DOI: 10.26442/00403660.2022.09.201840
13. Safiullina A. A., UskachT.M., DobrovolskayaS. V., SaidovaM. A., MakeevM. I., TereshchenkoS. N. Reverse remodeling against the background of cardiac contractility modulation therapy in patients with heart failure and atrial fibrillation. Cardiovascular Therapy and Prevention. 2022;21(2):2948. (In Russ.) https://doi.org/10.15829/1728-8800-2022-2948.
14. Safiullina AA, Uskach TM, Sharapova YS, Kochetov AG, Sapelnikov OV, Tereshchenko SN. Dynamics of Holter electrocardiogram monitoring in patients with chronic heart failure and atrial fibrillation on the background of cardiac contractility modulation. Terapevticheskii Arkhiv (Ter. Arkh.). 2021; 93 (9): 1044-1051. DOI: 10.26442/00403660.2021.09.201034.
15. Implantable pulse generator OPTIMIZER® Smart. Instructions for use. Part number: 13-290-008 ru -2016. -[Electronic resource]. URL: https://impulsedynamics.com/global/wp-content/uploads/sites/2/2020/10/13-290-008 ruOPTIMIZER-Smart-IPG-IFU-Russian-Rev 10. pdf.
Review
For citations:
Amanatova V.A., Uskach T.M., Vashtanian A.K., Drozdov D.V. Interpretation of electrocardiograms and results of daily ECG Holter monitoring in patients with an implanted cardiac contractility modulator. Medical alphabet. 2024;1(6):21-26. (In Russ.) https://doi.org/10.33667/2078-5631-2024-6-21-26
Views:
302
Email this article 